Sweden· SE-20050719000031
Kaletra 200 mg/50 mg Filmdragerad tablett
A medicinal product containing lopinavir + ritonavir, registered in Sweden by AbbVie Deutschland GmbH & Co KG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lopinavir + Ritonavir
- Manufacturer
- AbbVie Deutschland GmbH & Co KG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050719000031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lopinavir + ritonavir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKaletraAbbVie Inc.
- CzechiaKALETRAAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- FinlandKaletraAbbVie Deutschland GmbH&Co.KG
- United KingdomKaletra 100mg/25mg tabletsAbbVie Ltd
- SpainKALETRA (80 MG + 20 MG)/ML SOLUCION ORALAbbvie Deutschland Gmbh & Co. Kg
- NetherlandsKaletra (80 mg + 20 mg) /ml drankAbbVie Deutschland GmbH & Co. KG
- IrelandKaletraAbbVie Deutschland GmbH & Co. KG
- FranceKALETRA (80 mg + 20 mg)/ml, solution buvableABBVIE DEUTSCHLAND (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Estonia · Lopinavir/Ritonavir Ranbaxy, Lopinavir/Ritonavir Sun
- Spain · Lopinavir / Ritonavir Accord
- France · Lopinavir/Ritonavir Dextreg
- United Kingdom (Northern Ireland) · Kaletra, Lopinavir / Ritonavir Accord
- Iceland · Kaletra, Lopinavir/Ritonavir Mylan
- Liechtenstein · Kaletra, Lopinavir/Ritonavir Viatris
- Lithuania · Lopinavir / Ritonavir Sun, Lopinavir /Ritonavir Ranbaxy
- Latvia · Lopinavir/ Ritonavir Ranbaxy, Lopinavir/ Ritonavir Sun
- Netherlands · Lopinavir/Ritonavir Accord
- Norway · Kaletra, Lopinavir/Ritonavir Viatris
- Portugal · Lopinavir + Ritonavir Farmoz
- Slovenia · Lopinavir/Ritonavir Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdec90fd-3059-458b-a678-b25ffb3bc799 GET /v1/drugs/cdec90fd-3059-458b-a678-b25ffb3bc799?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20050719000031",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050719000031",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/kaletra-epar-product-information_sv.pdf"
}See everything about lopinavir + ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.